Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemcitabine and NAB-paclitaxel therapy in advanced pancreatic cancer.
第一作者:
David,Easty
第一单位:
Cancer Trials Ireland, 121 St. Stephen's Green, Dublin 2, Dublin, D02 H903, Ireland. david.easty@cancertrials.ie.;Beaumont Hospital, Dublin 9, Dublin, Ireland. david.easty@cancertrials.ie.;Our Lady Of Lourdes Hospital, Drogheda, Louth, Ireland. david.easty@cancertrials.ie.
作者:
DOI
10.1186/s12885-025-14512-2
PMID
41535788
发布时间
2026-01-15
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



